Evolution of glucose-lowering therapies

This module summarises evidence from cardiovascular outcomes trials (CVOTs) across glucose-lowering therapy classes, which have led to major updates to global diabetes, cardiology and kidney disease guidelines.

Evolution of glucose-lowering therapies
Rate this content
  • Evolution of glucose-lowering therapies
  • Contents
  • Contents
  • CV safety signals with glucose-lowering therapies led to new regulatory requirements in 2008
  • Some glucose-lowering therapies now show CV benefit as well as CV safety
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go